Pacific Biosciences Of California Return on Investment 2010-2023 | PACB
Pacific Biosciences Of California ROI - Return on Investment Historical Data | |||
---|---|---|---|
Date | TTM Net Income | LT Investments & Debt | Return on Investment |
2023-12-31 | $-0.33B | $1.59B | -41.11% |
2023-09-30 | $-0.33B | $1.66B | -42.75% |
2023-06-30 | $-0.33B | -43.71% | |
2023-03-31 | $-0.32B | -28.15% | |
2022-12-31 | $-0.31B | $1.46B | -19.90% |
2022-09-30 | $-0.29B | $1.52B | -17.82% |
2022-06-30 | $-0.29B | $1.58B | -17.19% |
2022-03-31 | $-0.26B | $1.63B | -16.43% |
2021-12-31 | $-0.21B | $1.69B | -14.67% |
2021-09-30 | $-0.17B | $1.74B | -16.72% |
2021-06-30 | $-0.12B | $1.15B | -20.60% |
2021-03-31 | $-0.11B | $1.18B | -36.05% |
2020-12-31 | $-0.11B | inf% | |
2020-09-30 | $-0.10B | inf% | |
2020-06-30 | $-0.10B | inf% | |
2020-03-31 | $-0.10B | inf% | |
2019-12-31 | $-0.10B | inf% | |
2019-09-30 | $-0.11B | -350.39% | |
2019-06-30 | $-0.11B | -160.00% | |
2019-03-31 | $-0.11B | -115.20% | |
2018-12-31 | $-0.10B | $0.13B | -82.93% |
2018-09-30 | $-0.09B | $0.15B | -79.48% |
2018-06-30 | $-0.09B | $0.10B | -82.98% |
2018-03-31 | $-0.09B | $0.12B | -80.00% |
2017-12-31 | $-0.09B | $0.10B | -85.71% |
2017-09-30 | $-0.09B | $0.11B | -82.66% |
2017-06-30 | $-0.08B | $0.13B | -77.54% |
2017-03-31 | $-0.08B | $0.08B | -72.21% |
2016-12-31 | $-0.07B | $0.10B | -65.01% |
2016-09-30 | $-0.06B | $0.11B | -51.16% |
2016-06-30 | $-0.04B | $0.12B | -37.63% |
2016-03-31 | $-0.03B | $0.10B | -37.84% |
2015-12-31 | $-0.03B | $0.09B | -45.34% |
2015-09-30 | $-0.05B | $0.06B | -78.95% |
2015-06-30 | $-0.06B | $0.05B | -93.72% |
2015-03-31 | $-0.06B | $0.06B | -95.45% |
2014-12-31 | $-0.06B | $0.07B | -83.22% |
2014-09-30 | $-0.06B | $0.07B | -78.21% |
2014-06-30 | $-0.07B | $0.07B | -85.38% |
2014-03-31 | $-0.08B | $0.09B | -78.53% |
2013-12-31 | $-0.08B | $0.08B | -75.18% |
2013-09-30 | $-0.08B | $0.10B | -100.00% |
2013-06-30 | $-0.09B | $0.11B | -93.99% |
2013-03-31 | $-0.09B | $0.12B | -88.12% |
2012-12-31 | $-0.10B | -84.77% | |
2012-09-30 | $-0.10B | $0.13B | -59.88% |
2012-06-30 | $-0.10B | $0.15B | -56.36% |
2012-03-31 | $-0.10B | $0.17B | -50.43% |
2011-12-31 | $-0.11B | $0.20B | -49.00% |
2011-09-30 | $-0.12B | $0.21B | -50.36% |
2011-06-30 | $-0.14B | $0.24B | -62.17% |
2011-03-31 | $-0.15B | $0.25B | -91.54% |
2010-12-31 | $-0.14B | $0.28B | -146.11% |
2010-06-30 | $-0.09B | inf% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.943B | $0.201B |
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $216.898B | 26.41 |
Intuitive Surgical (ISRG) | United States | $140.939B | 87.97 |
Edwards Lifesciences (EW) | United States | $56.173B | 37.22 |
DexCom (DXCM) | United States | $53.945B | 92.67 |
IQVIA Holdings (IQV) | United States | $44.965B | 26.67 |
IDEXX Laboratories (IDXX) | United States | $44.087B | 52.69 |
Alcon (ALC) | Switzerland | $40.745B | 30.05 |
STERIS (STE) | Ireland | $21.889B | 25.91 |
Waters (WAT) | United States | $20.016B | 28.77 |
Hologic (HOLX) | United States | $17.880B | 19.73 |
SONOVA HOLDING (SONVY) | Switzerland | $16.949B | 0.00 |
ShockWave Medical (SWAV) | United States | $11.820B | 81.67 |
Sysmex ADR (SSMXY) | Japan | $11.167B | 35.03 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.097B | 13.70 |
Teleflex (TFX) | United States | $10.183B | 16.00 |
Penumbra (PEN) | United States | $8.548B | 105.68 |
Masimo (MASI) | United States | $7.442B | 41.74 |
Globus Medical (GMED) | United States | $6.988B | 22.16 |
Glaukos (GKOS) | United States | $4.438B | 0.00 |
Integer Holdings (ITGR) | United States | $3.726B | 23.88 |
LivaNova (LIVN) | United Kingdom | $2.935B | 19.36 |
Elekta AB (EKTAY) | Sweden | $2.902B | 19.91 |
Inari Medical (NARI) | United States | $2.673B | 461.10 |
Integra LifeSciences Holdings (IART) | United States | $2.653B | 10.89 |
TransMedics (TMDX) | United States | $2.436B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $2.366B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.330B | 19.71 |
Tandem Diabetes Care (TNDM) | United States | $2.211B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.850B | 0.00 |
RxSight (RXST) | United States | $1.818B | 0.00 |
Veracyte (VCYT) | United States | $1.545B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.905B | 16.74 |
Paragon 28 (FNA) | United States | $0.849B | 0.00 |
Artivion (AORT) | United States | $0.846B | 97.76 |
Silk Road Medical (SILK) | United States | $0.745B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.709B | 0.00 |
OPKO Health (OPK) | United States | $0.704B | 0.00 |
SiBone (SIBN) | United States | $0.628B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.619B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.552B | 18.74 |
IRadimed (IRMD) | United States | $0.539B | 31.32 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.509B | 0.00 |
Nevro (NVRO) | United States | $0.494B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.454B | 0.00 |
CVRx (CVRX) | United States | $0.378B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.367B | 12.37 |
NeuroPace (NPCE) | United States | $0.350B | 0.00 |
AxoGen (AXGN) | United States | $0.326B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.269B | 0.00 |
Sight Sciences (SGHT) | United States | $0.249B | 0.00 |
Accuray (ARAY) | United States | $0.235B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.226B | 0.00 |
908 Devices (MASS) | United States | $0.217B | 0.00 |
AngioDynamics (ANGO) | United States | $0.215B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.207B | 0.00 |
Semler Scientific (SMLR) | United States | $0.200B | 10.77 |
Inogen (INGN) | United States | $0.181B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.176B | 0.00 |
Neuronetics (STIM) | United States | $0.142B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.122B | 0.00 |
Delcath Systems (DCTH) | United States | $0.102B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
Envoy Medical (COCH) | United States | $0.079B | 0.00 |
Hyperfine (HYPR) | United States | $0.077B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.072B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.071B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.065B | 133.00 |
Vicarious Surgical (RBOT) | United States | $0.056B | 0.00 |
Vasomedical (VASO) | United States | $0.056B | 4.29 |
Autonomix Medical (AMIX) | $0.055B | 0.00 | |
InspireMD (NSPR) | Israel | $0.053B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.046B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
DarioHealth (DRIO) | United States | $0.041B | 0.00 |
LENSAR (LNSR) | United States | $0.040B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.040B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.036B | 0.00 |
Spectral AI (MDAI) | United States | $0.036B | 0.00 |
Precision Optics (POCI) | United States | $0.036B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.027B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
PAVmed (PAVM) | United States | $0.019B | 0.00 |
PetVivo Holdings (PETV) | United States | $0.017B | 0.00 |
NexGel (NXGL) | United States | $0.016B | 0.00 |
Check-Cap (CHEK) | Israel | $0.014B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.011B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
Avinger (AVGR) | United States | $0.005B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |